Clinical Trials
2 trialsNCT06745583 2026-06-03
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Phase 2 Recruiting
NCT04635657 2026-05-22
Cognitive Status After Removal of Skull Base Meningioma
Ohio State University
Recruiting